ICU Management & Practice, ICU Volume 9 - Issue 3 - Autumn 2009
A recent study by The New England Journal of Medicine found pneumonia to be the second most common cause of rehospitalisation within 30 days after surgery.1 It's this kind of real-world need that drives our search for relevant innovations—innovations like the Mallinckrodt™ TaperGuard™ endotracheal tube, shown to reduce microaspiration an average of 90% compared with our own Mallinckrodt™ Hi-Lo™ cuff.2 To learn more about the Mallinckrodt™ TaperGuard™ endotracheal tube, visit respiratorysolutions.covidien.com.
